Standard
Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes. / Stensen, S.; Gasbjerg, L. S.; Rosenkilde, M. M.; Hartmann, B.; Vilsboll, T.; Holst, J. J.; Christensen, M. B.; Knop, F. K.
In:
Diabetologia, Vol. 64, No. SUPPL 1, 179, 2021, p. 95-95.
Research output: Contribution to journal › Conference abstract in journal › Research
Harvard
Stensen, S
, Gasbjerg, LS, Rosenkilde, MM, Hartmann, B, Vilsboll, T, Holst, JJ, Christensen, MB
& Knop, FK 2021, '
Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes',
Diabetologia, vol. 64, no. SUPPL 1, 179, pp. 95-95.
https://doi.org/10.1007/s00125-021-05519-yAPA
Stensen, S.
, Gasbjerg, L. S., Rosenkilde, M. M., Hartmann, B., Vilsboll, T., Holst, J. J., Christensen, M. B.
, & Knop, F. K. (2021).
Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes.
Diabetologia,
64(SUPPL 1), 95-95. [179].
https://doi.org/10.1007/s00125-021-05519-yVancouver
Stensen S
, Gasbjerg LS, Rosenkilde MM, Hartmann B, Vilsboll T, Holst JJ et al.
Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes.
Diabetologia. 2021;64(SUPPL 1):95-95. 179.
https://doi.org/10.1007/s00125-021-05519-yAuthor
Stensen, S. ; Gasbjerg, L. S. ; Rosenkilde, M. M. ; Hartmann, B. ; Vilsboll, T. ; Holst, J. J. ; Christensen, M. B. ; Knop, F. K. / Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes. In: Diabetologia. 2021 ; Vol. 64, No. SUPPL 1. pp. 95-95.
Bibtex
@article{972bbf7922d74636be88c32f6454b302,
title = "Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes",
author = "S. Stensen and Gasbjerg, {L. S.} and Rosenkilde, {M. M.} and B. Hartmann and T. Vilsboll and Holst, {J. J.} and Christensen, {M. B.} and Knop, {F. K.}",
year = "2021",
doi = "10.1007/s00125-021-05519-y",
language = "English",
volume = "64",
pages = "95--95",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "SUPPL 1",
}
RIS
TY - ABST
T1 - Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes
AU - Stensen, S.
AU - Gasbjerg, L. S.
AU - Rosenkilde, M. M.
AU - Hartmann, B.
AU - Vilsboll, T.
AU - Holst, J. J.
AU - Christensen, M. B.
AU - Knop, F. K.
PY - 2021
Y1 - 2021
U2 - 10.1007/s00125-021-05519-y
DO - 10.1007/s00125-021-05519-y
M3 - Conference abstract in journal
C2 - 34468792
VL - 64
SP - 95
EP - 95
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - SUPPL 1
M1 - 179
ER -
